Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of NASH

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
A Phase II, Randomized, Double Blind, Placebo-Controlled Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients with Apparent Risk Factors of Nonalcoholic Steatohepatitis (NASH)
Epistemonikos ID: 9b498180472332ef9130d0bf76f94185728c24e3
First added on: Dec 20, 2022